Join Dr. Phil Morton, Albumedix' Chief Technology Officer and Dr. Takehiko Kaneko, Head of R&D and Chief Medical Officer of Heartseed, to explore:

• The journey of Heartseed's investigative cardiomyocyte therapy for heart failure patients, now in Phase I/II clinical trials
• The value albumin delivers across advanced therapy applications
• How implementing Recombumin® into a manufacturing process can help improve production and support stability
• The key benefits of using chemically defined raw materials
• And more...

For details: https://www.fiercebiotech.com/premium/webinar/bringing-new-heart-failure-therapy-clinic